Singapore markets close in 6 hours 21 minutes
Straits Times Index
3,303.28 -0.38 (-0.01%) Nikkei
38,158.74 -20.72 (-0.05%) Hang Seng
19,171.99 +56.93 (+0.30%) FTSE 100
8,414.99 -18.77 (-0.22%) Bitcoin USD
62,644.05 +1,598.43 (+2.62%) CMC Crypto 200
1,287.73 +27.53 (+2.18%)
GILD May 2024 61.000 put
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 11:01AM EDT. Market open.
| Previous close | 0.1000 |
| Open | 0.2500 |
| Bid | 0.0200 |
| Ask | 0.2600 |
| Strike | 61.00 |
| Expiry date | 2024-05-24 |
| Day's range | 0.1000 - 0.2500 |
| Contract range | N/A |
| Volume | |
| Open interest | 177 |
Yahoo FinanceOne stock is dragging down the S&P 500's earnings growth
S&P 500 companies have had a solid Q1 earnings season, with one key exception: drugmaker Bristol Myers Squibb.
ZacksGilead Sciences, Inc. (GILD) is Attracting Investor Attention: Here is What You Should Know
Zacks.com users have recently been watching Gilead (GILD) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Business WireKite and Arcellx Continue Momentum with Advances in Anito-Cel Multiple Myeloma Program
REDWOOD CITY, Calif. & SANTA MONICA, Calif., May 09, 2024--Kite, a Gilead Company (NASDAQ: GILD), and Arcellx, Inc. (NASDAQ: ACLX) today announced several key operational updates on their partnered anitocabtagene autoleucel (anito-cel) multiple myeloma program. Anito-cel is the first BCMA CAR T to be investigated in multiple myeloma that utilizes Arcellx’s novel and compact D-Domain binder.
© 2024 Yahoo. All rights reserved.